|
|
Volumn 8, Issue 10, 2006, Pages 761-763
|
|
A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy
a
|
|
Author keywords
Complete clinical response; Metastatic breast cancer; Trastuzumab
|
|
Indexed keywords
AMIKACIN;
CEFTAZIDIME;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
HORMONE RECEPTOR;
LETROZOLE;
METHOTREXATE;
TAMOXIFEN;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CISPLATIN;
CMF PROTOCOL;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
BREAST CANCER;
CANCER MORTALITY;
CANCER PATIENT;
CASE REPORT;
DRUG POTENTIATION;
DRUG RESPONSE;
FEBRILE NEUTROPENIA;
FEMALE;
FOLLOW UP;
GENE OVEREXPRESSION;
HUMAN;
JAUNDICE;
LIVER FAILURE;
LIVER METASTASIS;
LOADING DRUG DOSE;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
PATIENT CARE;
AGED;
BIOPSY;
BONE TUMOR;
BREAST;
BREAST TUMOR;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE FREE SURVIVAL;
KARNOFSKY PERFORMANCE STATUS;
LIVER TUMOR;
LYMPH NODE METASTASIS;
MASTECTOMY;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PAGET NIPPLE DISEASE;
PATHOLOGY;
RADIATION DOSE;
RADIOGRAPHY;
TIME;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY;
BONE NEOPLASMS;
BREAST;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
KARNOFSKY PERFORMANCE STATUS;
LIVER NEOPLASMS;
LYMPHATIC METASTASIS;
MASTECTOMY, MODIFIED RADICAL;
METHOTREXATE;
RADIOTHERAPY DOSAGE;
RECEPTOR, ERBB-2;
TAMOXIFEN;
TIME FACTORS;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
|
EID: 39049175216
PISSN: 1699048X
EISSN: None
Source Type: Journal
DOI: 10.1007/s12094-006-0125-6 Document Type: Article |
|
Times cited : (14)
|
|
References (4)
|
